VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ENTA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ENTAEnanta Pharmaceuticals, Inc.
$14.51$337M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksENTAPrice History

ENTA logoEnanta Pharmaceuticals, Inc. (ENTA) Stock Price History

Historical prices from 2013 to 2026

$14.51-0.60  (-3.97%)close Jul 6
Returns
1M
+31.1%
3M
+9.5%
YTD
+0.6%
1Y
+89.7%
3Y
-10.2%
5Y
-19.8%
ATH$127.77Jul 2018-88.6%
ATL$4.09Apr 2025pre-split
Avg Vol (50D)204K/ day
52-Week Range$6.44 — $17.15
LowCurrent: $14.51High

Loading 10-year price history...

ENTA Historical Performance

1 YearTotal Return
+89.7%
Price: +89.7%
3 YearsTotal Return
-27.7%
CAGR: -10.2%
Price: -27.7%
5 YearsTotal Return
-66.8%
CAGR: -19.8%
Price: -66.8%
YTD
+0.6%

ENTA Annual Returns

Year-by-year price performance · 2013–2026

Best+182.1%2025
Worst-79.4%2023
Up years6/14
2013+58.8%
2014+79.8%
2015-34.5%
2016-2.0%
2017+70.8%
2018+22.2%
2019-14.6%
2020-32.1%
2021+77.6%
2022-37.2%
2023-79.4%
2024-43.0%
2025+182.1%
2026-0.8%
2013 annual price return
+58.8%
2014 annual price return
+79.8%
2015 annual price return
-34.5%
2016 annual price return
-2.0%
2017 annual price return
+70.8%
2018 annual price return
+22.2%
2019 annual price return
-14.6%
2020 annual price return
-32.1%
2021 annual price return
+77.6%
2022 annual price return
-37.2%
2023 annual price return
-79.4%
2024 annual price return
-43.0%
2025 annual price return
+182.1%
2026 annual price return
-0.8%
LessMore
Alpha vs S&P 500
1Y+66.6%
3Y-33.5%
5Y-33.2%

Price returns only.

Download Historical Data

3,343 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

ENTA Stock Price Trajectory (2013–2026)

As of July 7, 2026, Enanta Pharmaceuticals, Inc. (ENTA) trades at $14.51, representing a +89.7% return over the past year. The stock has delivered a -66.8% total return over five years (-19.8% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $127.77 on July 6, 2018. From this peak, ENTA has corrected -88.6%, currently trading 12% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers ACHV (+211.6% 1Y), AGIO (+6.2% 1Y), and ARQT (+94.7% 1Y), ENTA has underperformed the peer group average. Compare ENTA vs ACHV →

ENTA Historical Price Data · from 2013

Rows 1–50 of 3,343
Date Open High Low Close Volume Change %
2026-07-0614.9015.1014.4314.51197K-3.97%
2026-07-0214.9415.5114.8315.11296K+2.30%
2026-07-0114.6315.2014.6314.77198K+1.30%
2026-06-3014.5314.6614.2614.58271K+0.48%
2026-06-2914.1414.7313.9714.51335K+3.64%
2026-06-2613.5114.2513.4314.000+4.09%
2026-06-2513.9214.2013.3213.45174K-1.97%
2026-06-2414.0814.5513.6713.72275K-2.42%
2026-06-2312.9714.1012.9214.06395K+5.16%
2026-06-2212.6113.4112.6113.37218K+5.61%
2026-06-1812.8713.0612.4812.66245K+0.16%
2026-06-1712.0512.6512.0512.64162K+4.72%
2026-06-1611.4412.0711.3312.07128K+5.51%
2026-06-1511.9512.2211.4211.44112K-3.87%
2026-06-1211.4812.1011.1111.90190K+3.39%
2026-06-1111.7511.7511.1811.51261K-1.62%
2026-06-1011.1811.7511.1811.70130K+3.08%
2026-06-0911.2311.5511.0511.35117K+2.53%
2026-06-0811.6613.2310.8611.07154K-1.86%
2026-06-0511.6811.6811.2511.28129K-3.84%
2026-06-0411.3311.9911.3311.73182K+4.36%
2026-06-0311.9212.0311.1711.24368K-6.57%
2026-06-0212.5112.7511.9112.03187K-5.05%
2026-06-0113.2813.3112.5012.67171K-3.72%
2026-05-2913.4413.4413.0613.16176K-0.53%
2026-05-2813.2213.4613.1213.23152K+0.30%
2026-05-2713.6213.8513.1013.19291K-2.51%
2026-05-2614.2714.2713.3813.53305K-3.01%
2026-05-2213.9414.4013.7913.95137K+0.87%
2026-05-2113.5013.9613.4013.83136K+1.62%
2026-05-2013.7614.2413.5413.61159K-1.09%
2026-05-1913.3813.9013.3513.76202K+2.30%
2026-05-1813.4313.8613.2413.45257K+0.30%
2026-05-1513.9714.0013.1913.41210K-2.90%
2026-05-1414.0414.1213.5513.81266K-1.57%
2026-05-1314.3714.9114.0314.03142K-3.44%
2026-05-1214.6015.3513.5914.53367K-6.02%
2026-05-1115.5515.8915.1015.46280K+0.78%
2026-05-0815.0615.7015.0015.34189K+1.66%
2026-05-0715.2215.9314.7815.09194K-0.98%
2026-05-0614.4015.2814.4015.24347K+5.25%
2026-05-0514.6714.9413.8114.48249K-0.41%
2026-05-0414.1914.9314.0914.54144K+1.32%
2026-05-0113.7414.4713.7414.35146K+3.31%
2026-04-3013.8714.2713.5713.89153K+0.14%
2026-04-2913.3113.9213.3113.87114K+1.17%
2026-04-2813.4913.7813.2613.7196K+3.24%
2026-04-2713.2613.8713.2013.2881K-0.23%
2026-04-2413.2713.5213.0813.31159K-0.30%
2026-04-2313.7914.0013.2713.3575K-3.19%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

ENTA — Frequently Asked Questions

Quick answers to the most common questions about buying ENTA stock.

How has ENTA stock performed recently?

ENTA returned +89.7% over the past year, beating its 5-year annualized CAGR of -19.8%. The stock trades above its 200-day moving average, confirming the uptrend.

What is ENTA's all-time high price?

Enanta Pharmaceuticals, Inc. reached $127.77 on 2018-07-06. The 52-week high is $17.15. Current 1-year return of +89.7% places the stock closer to historical peaks.

Where can I download ENTA historical price data?

This page provides ENTA daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2013-2026, downloadable in CSV format.

479 data points · sampled from 3,343